A computational workflow for the design of irreversible inhibitors of protein kinases

被引:0
|
作者
Alberto Del Rio
Miriam Sgobba
Marco Daniele Parenti
Gianluca Degliesposti
Rosetta Forestiero
Claudia Percivalle
Pier Franco Conte
Mauro Freccero
Giulio Rastelli
机构
[1] Università di Modena e Reggio Emilia,Dipartimento di Scienze Farmaceutiche
[2] Università di Pavia,Dipartimento di Chimica Organica
[3] Università di Modena e Reggio Emilia,Dipartimento di Oncologia ed Ematologia
关键词
Protein kinases; ERK2; Irreversible inhibition; Cysteine trap; Michael acceptors; Binding free energy; Molecular dynamics; Generalized amber force field;
D O I
暂无
中图分类号
学科分类号
摘要
Design of irreversible inhibitors is an emerging and relatively less explored strategy for the design of protein kinase inhibitors. In this paper, we present a computational workflow that was specifically conceived to assist such design. The workflow takes the form of a multi-step procedure that includes: the creation of a database of already known reversible inhibitors of protein kinases, the selection of the most promising scaffolds that bind one or more desired kinase templates, the modification of the scaffolds by introduction of chemically reactive groups (suitable cysteine traps) and the final evaluation of the reversible and irreversible protein–ligand complexes with molecular dynamics simulations and binding free energy predictions. Most of these steps were automated. In order to prove that this is viable, the workflow was tested on a database of known inhibitors of ERK2, a protein kinase possessing a cysteine in the ATP site. The modeled ERK2-ligand complexes and the values of the estimated binding free energies of the putative ligands provide useful indicators of their aptitude to bind reversibly and irreversibly to the protein kinase. Moreover, the computational data are used to rank the ligands according to their computed binding free energies and their ability to bind specific protein residues in the reversible and irreversible complexes, thereby providing a useful decision-making tool for each step of the design. In this work we present the overall procedure and the first proof of concept results.
引用
收藏
页码:183 / 194
页数:11
相关论文
共 50 条
  • [31] Peptide Inhibitors Targeting Protein Kinases
    Eldar-Finkelman, Hagit
    Eisenstein, Miriam
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (21) : 2463 - 2470
  • [32] Development of inhibitors for protein tyrosine kinases
    Fahad A Al-Obeidi
    Kit S Lam
    Oncogene, 2000, 19 : 5690 - 5701
  • [33] Special issue: Inhibitors of protein kinases
    Shugar, David
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (01): : 1 - 2
  • [34] Deactivatable Bisubstrate Inhibitors of Protein Kinases
    Sormus, Tanel
    Lavogina, Darja
    Enkvist, Erki
    Uri, Asko
    Viht, Kaido
    MOLECULES, 2022, 27 (19):
  • [35] Bivalent inhibitors of protein tyrosine kinases
    Profit, AA
    Lee, TR
    Lawrence, DS
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (02) : 280 - 283
  • [36] In silico profiling of protein kinases inhibitors
    Reys, Victor
    Labesse, Gilles
    M S-MEDECINE SCIENCES, 2020, 36 : 38 - 41
  • [37] Development of inhibitors for protein tyrosine kinases
    Al-Obeidi, FA
    Lam, KS
    ONCOGENE, 2000, 19 (49) : 5690 - 5701
  • [38] INHIBITORS OF PROTEIN-KINASES AND PHOSPHATASES
    MACKINTOSH, C
    MACKINTOSH, RW
    TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (11) : 444 - 448
  • [39] INHIBITORS OF PROTEIN-TYROSINE KINASES
    FRY, DW
    BRIDGES, AJ
    CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 662 - 667
  • [40] Cell-Active, Arginine-Targeting Irreversible Covalent Inhibitors for Non-Kinases and Kinases
    Chen, Peng
    Wang, Lu
    Wang, Xuan
    Sun, Jie
    Miao, Fengfei
    Wang, Zuqin
    Yang, Fang
    Xiang, Menghua
    Gu, Mingxi
    Li, Shengrong
    Zhang, Jianzhong
    Yuan, Peiyan
    Lu, Xiaoyun
    Zhang, Zhi-Min
    Gao, Liqian
    Yao, Shao Q.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025,